European Wellness Returns to ADAMS 2026 with New Advances in Regenerative Medicine

KUALA LUMPUR, Malaysia (July 4, 2026) — European Wellness Biomedical Group (EWBG) is once again taking center stage at the Asia Dermatology & Aesthetic Medicine Summit (ADAMS) 2026, returning as a Diamond Sponsor while presenting one of the event’s strongest scientific programs focused on regenerative medicine, stem cells, exosomes, peptides, and longevity science.

Held on July 4–5, 2026 at the Grand Ballroom, Basement II, Shangri-La Hotel Kuala Lumpur, ADAMS has established itself as one of Asia’s leading educational platforms, bringing together internationally renowned physicians, researchers, aesthetic practitioners, and healthcare innovators to discuss the latest developments in dermatology, aesthetic medicine, anti-aging, and regenerative healthcare.

As a long-standing supporter of scientific education, European Wellness returns this year not only as a major industry partner but also with a distinguished faculty of international experts sharing the latest evidence, clinical experience, and emerging therapies in precision regenerative medicine.

Leading the scientific program is Prof. Dato’ Sri Dr. Mike Chan, Founder and Chairman of European Wellness Biomedical Group, who will deliver two keynote presentations on the opening day.

His first lecture, “Stem Cells, Exosomes, and Peptides Untold: What Works Better and What’s Not,” examines the current scientific evidence behind three of today’s most discussed regenerative therapies, comparing their respective strengths, limitations, and appropriate clinical applications. The presentation aims to provide physicians with practical guidance in distinguishing proven therapies from misconceptions within the rapidly evolving field.

Later in the afternoon, Prof. Chan presented “Mitochondrial Peptides in Longevity Regenerative Medicine from Fertility to Longevity,” highlighting the growing role of mitochondrial signaling peptides in healthy aging, metabolic optimization, reproductive medicine, cellular repair, and longevity-focused healthcare.

Joining him was internationally respected regenerative medicine specialist Prof. Dr. Dmytro, whose presentations explored the future of cellular medicine. His sessions covered advances in tissue regeneration, organ failure treatment, cellular replacement therapies, and the expanding role of peptide therapy in everyday regenerative and longevity medicine.

Completing the European Wellness faculty is Dr. Glen Alvin, who presented his lecture on the second day focusing on novel anti-aging therapies as well as the clinical application of peptides and exosomes in aesthetics, showcasing practical approaches that bridge regenerative science with modern aesthetic medicine.

Beyond the scientific program, delegates got   the opportunity to visit European Wellness at Booth, where the company showcased its latest regenerative medicine innovations together with its flagship brands, European Wellness, MF3, and MF Plus. Visitors crowded the booth to learn more about advances in organ-specific precursor stem cell therapy, precision regenerative protocols, peptide therapeutics, exosome technologies, and evidence-based longevity medicine.

Advancing Regenerative Medicine Through Knowledge Sharing

European Wellness has consistently supported ADAMS since its earlier editions, reflecting the company’s long-term commitment to physician education, scientific collaboration, and the responsible advancement of regenerative medicine across Asia. The group’s continued participation underscores its mission of translating cutting-edge biomedical research into practical clinical solutions that improve patient outcomes and promote healthier aging.

Opening the conference was Dato Dr. Ko Chung Beng. Chairman of The ADAMS 2026 Organizing Committee. A consultant dermatologist, Dr. Ko reminded delegates that excellence in medicine is never a destination but an ongoing journey of learning.

“When we first chose this theme, many people naturally associated the word ‘pinnacle’ with reaching the highest level of achievement. To me, however, it carries a different meaning. In medicine, I don’t believe there is ever a point where we can truly say we have reached the pinnacle because medicine keeps changing.”

Reflecting on more than three decades in clinical practice, Dr. Ko said every patient continues to teach doctors something new.

“The longer I practice medicine, the more I realize there’s always something new to learn. Every patient teaches us something different, new evidence continues to emerge, and every discussion with colleagues offers another perspective.”

He explained that this philosophy was the inspiration behind establishing ADAMS many years ago.

Dr Ko added this year’s program reflects many of the fastest-growing fields in healthcare, including regenerative medicine, longevity science, energy-based technologies, and artificial intelligence.

While welcoming innovation, Dr. Ko also reminded delegates that scientific evidence and patient safety must remain the profession’s guiding principles.

“Every year brings new possibilities. These innovations are exciting, and we should embrace them. But not every new technology automatically becomes good medicine. Our responsibility is to evaluate every treatment carefully, guided by scientific evidence, sound clinical judgment, and, above all, patient safety,” added Dr Ko.

As regenerative medicine continues to transform the future of healthcare, ADAMS 2026 provides an important platform for knowledge exchange, interdisciplinary collaboration, and the sharing of scientific breakthroughs that are shaping the next generation of personalized medicine.